New Bifunctional Chelators Incorporating Dibromomaleimide Groups for Radiolabeling of Antibodies with Positron Emission Tomography Imaging Radioisotopes

Positron Emission Tomography (PET) imaging with antibody-based contrast agents frequently uses the radioisotopes [{64}^Cu]Cu^{2+} and [{89}^Zr]Zr^{4+}. The macrobicyclic chelator commonly known as sarcophagine (sar) is ideal for labeling receptor-targeted biomolecules with [{64}^Cu]Cu^{2+}. The siderophore chelator, desferrioxamine-B (dfo), has been widely used to incorporate [{89}^Zr]Zr^{4+}, respectively, in near quantitative radiochemical yield (>99%). Serum stability studies, in vivo PET imaging, and biodistribution analyses using these radiolabeled immunoconjugates demonstrate that both [{64}^Cu]Cu-sar–dtm–trastuzumab and [{89}^Zr]Zr-dfo–dtm–trastuzumab possess high stability in biological milieu. Dibromomaleimide technology can be easily applied to enable stable, site-specific attachment of radiolabeled chelators, such as sar and dfo, to native interstrand disulfide regions of antibodies, enabling tracking of antibodies with PET imaging

Characterisation of the Immunophenotype of Dogs with Primary Immune-Mediated Haemolytic Anaemia

Immune-mediated haemolytic anaemia (IMHA) is reported to be the most common autoimmune disease of dogs, resulting in significant morbidity and mortality in affected animals. Haemolysis is caused by the action of autoantibodies, but the immunological changes that result in their production have not been elucidated.To investigate the frequency of regulatory T cells (Tregs) and other lymphocyte subsets and to measure serum concentrations of cytokines and peripheral blood mononuclear cell expression of cytokine genes in dogs with IMHA, healthy dogs and dogs with inflammatory diseases.19 dogs with primary IMHA, 22 dogs with inflammatory diseases and 32 healthy control dogs.Residual EDTA-anti-coagulated blood samples were stained with fluorophore-conjugated monoclonal antibodies and analysed by flow cytometry to identify Tregs and other lymphocyte subsets. Total RNA was also extracted from peripheral blood mononuclear cells to investigate cytokine gene expression, and concentrations of serum cytokines (interleukins 2, 6 10, CXCL-8 and tumour necrosis factor α) were measured using enhanced chemiluminescent assays. Principal component analysis was used to investigate latent variables that might explain variability in the entire dataset.There was no difference in the frequency or absolute numbers of Tregs among groups, nor in the proportions of other lymphocyte subsets. The concentrations of pro-inflammatory cytokines were greater in dogs with IMHA compared to healthy controls, but the concentration of IL-10 and the expression of cytokine genes did not differ between groups. Principal component analysis identified four components that explained the majority of the variability in the dataset, which seemed to correspond to different aspects of the immune response.The immunophenotype of dogs with IMHA differed from that of dogs with inflammatory diseases and from healthy control dogs; some of these changes could suggest abnormalities in peripheral tolerance that permit development of autoimmune disease. The frequency of Tregs did not differ between groups, suggesting that deficiency in the number of these cells is not responsible for development of IMHA

The influence of the accessory genome on bacterial pathogen evolution

Bacterial pathogens exhibit significant variation in their genomic content of virulence factors. This reflects the abundance of strategies pathogens evolved to infect host organisms by suppressing host immunity. Molecular arms-races have been a strong driving force for the evolution of pathogenicity, with pathogens often encoding overlapping or redundant functions, such as type III protein secretion effectors and hosts encoding ever more sophisticated immune systems. The pathogens’ frequent exposure to other microbes, either in their host or in the environment, provides opportunities for the acquisition or interchange of mobile genetic elements. These DNA elements accessorise the core genome and can play major roles in shaping genome structure and altering the complement of virulence factors. Here, we review the different mobile genetic elements focusing on the more recent discoveries and highlighting their role in shaping bacterial pathogen evolution

Mutational Patterns in RNA Secondary Structure Evolution Examined in Three RNA Families

The goal of this work was to study mutational patterns in the evolution of RNA secondary structure. We analyzed bacterial tmRNA, RNaseP and eukaryotic telomerase RNA secondary structures, mapping structural variability onto phylogenetic trees constructed primarily from rRNA sequences. We found that secondary structures evolve both by whole stem insertion/deletion, and by mutations that create or disrupt stem base pairing. We analyzed the evolution of stem lengths and constructed substitution matrices describing the changes responsible for the variation in the RNA stem length. In addition, we used principal component analysis of the stem length data to determine the most variable stems in different families of RNA. This data provides new insights into the evolution of RNA secondary structures and patterns of variation in the lengths of double helical regions of RNA molecules. Our findings will facilitate design of improved mutational models for RNA structure evolution

Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19

Plitidepsin, a marine-derived cyclic-peptide, inhibits SARS-CoV-2 replication at nanomolar concentrations by targeting the host protein eukaryotic translation elongation factor 1A. Here, we show that plitidepsin distributes preferentially to lung over plasma, with similar potency against across several SARS-CoV-2 variants in preclinical studies. Simultaneously, in this randomized, parallel, open-label, proof-of-concept study (NCT04382066) conducted in 10 Spanish hospitals between May and November 2020, 46 adult hospitalized patients with confirmed SARS-CoV-2 infection received either 1.5 mg (n = 15), 2.0 mg (n = 16), or 2.5 mg (n = 15) plitidepsin once daily for 3 d. The primary objective was safety; viral load kinetics, mortality, need for increased respiratory support, and dose selection were secondary end points. One patient withdrew consent before starting procedures; 45 initiated treatment; one withdrew because of hypersensitivity. Two Grade 3 treatment-related adverse events were observed (hypersensitivity and diarrhea). Treatment-related adverse events affecting more than 5% of patients were nausea (42.2%), vomiting (15.6%), and diarrhea (6.7%). Mean viral load reductions from baseline were 1.35, 2.35, 3.25, and 3.85 log10 at days 4, 7, 15, and 31. Nonmechanical invasive ventilation was required in 8 of 44 evaluable patients (16.0%); six patients required intensive care support (13.6%), and three patients (6.7%) died (COVID-19-related). Plitidepsin has a favorable safety profile in patients with COVID-19

Topology analysis and visualization of Potyvirus protein-protein interaction network

Background: One of the central interests of Virology is the identification of host factors that contribute to virus infection. Despite tremendous efforts, the list of factors identified remains limited. With omics techniques, the focus has changed from identifying and thoroughly characterizing individual host factors to the simultaneous analysis of thousands of interactions, framing them on the context of protein-protein interaction networks and of transcriptional regulatory networks. This new perspective is allowing the identification of direct and indirect viral targets. Such information is available for several members of the Potyviridae family, one of the largest and more important families of plant viruses. Results: After collecting information on virus protein-protein interactions from different potyviruses, we have processed it and used it for inferring a protein-protein interaction network. All proteins are connected into a single network component. Some proteins show a high degree and are highly connected while others are much less connected, with the network showing a significant degree of dissortativeness. We have attempted to integrate this virus protein-protein interaction network into the largest protein-protein interaction network of Arabidopsis thaliana, a susceptible laboratory host. To make the interpretation of data and results easier, we have developed a new approach for visualizing and analyzing the dynamic spread on the host network of the local perturbations induced by viral proteins. We found that local perturbations can reach the entire host protein-protein interaction network, although the efficiency of this spread depends on the particular viral proteins. By comparing the spread dynamics among viral proteins, we found that some proteins spread their effects fast and efficiently by attacking hubs in the host network while other proteins exert more local effects. Conclusions: Our findings confirm that potyvirus protein-protein interaction networks are highly connected, with some proteins playing the role of hubs. Several topological parameters depend linearly on the protein degree. Some viral proteins focus their effect in only host hubs while others diversify its effect among several proteins at the first step. Future new data will help to refine our model and to improve our predictions.This work was supported by the Spanish Ministerio de Economia y Competitividad grants BFU2012-30805 (to SFE), DPI2011-28112-C04-02 (to AF) and DPI2011-28112-C04-01 (to JP). The first two authors are recipients of fellowships from the Spanish Ministerio de Economia y Competitividad: BES-2012-053772 (to GB) and BES-2012-057812 (to AF-F).Bosque, G.; Folch Fortuny, A.; Picó Marco, JA.; Ferrer, A.; Elena Fito, SF. (2014). Topology analysis and visualization of Potyvirus protein-protein interaction network. BMC Systems Biology. 129(8):1-15. doi:10.1186/s12918-014-0129-8S1151298Gibbs A, Ohshima K: Potyviruses and the digital revolution. Annu Rev Phytopathol. 2010, 48: 205-223. 10.1146/annurev-phyto-073009-114404.Spence NJ, Phiri NA, Hughes SL, Mwaniki A, Simons S, Oduor G, Chacha D, Kuria A, Ndirangu S, Kibata GN, Marris GC: Economic impact of turnip mosaic virus, cauliflower mosaic virus and beet mosaic virus in three Kenyan vegetables. Plant Pathol. 2007, 56: 317-323. 10.1111/j.1365-3059.2006.01498.x.Ward CW, Shukla DD: Taxonomy of potyviruses: current problems and some solutions. Intervirology. 1991, 32: 269-296.Riechmann JL, Laín S, García JA: Highlights and prospects of potyvirus molecular biology. J Gen Virol. 1992, 73 (Pt 1): 1-16. 10.1099/0022-1317-73-1-1.Elena SF, Rodrigo G: Towards an integrated molecular model of plant-virus interactions. Curr Opin Virol. 2012, 2: 719-724. 10.1016/j.coviro.2012.09.004.Wei T, Zhang C, Hong J, Xiong R, Kasschau KD, Zhou X, Carrington JC, Wang A: Formation of complexes at plasmodesmata for potyvirus intercellular movement is mediated by the viral protein P3N-PIPO. PLoS Pathog. 2010, 6: e1000962-10.1371/journal.ppat.1000962.Chung BY-W, Miller WA, Atkins JF, Firth AE: An overlapping essential gene in the Potyviridae. Proc Natl Acad Sci. 2008, 105: 5897-5902. 10.1073/pnas.0800468105.Allison R, Johnston RE, Dougherty WG: The nucleotide sequence of the coding region of tobacco etch virus genomic RNA: evidence for the synthesis of a single polyprotein. Virology. 1986, 154: 9-20. 10.1016/0042-6822(86)90425-3.Domier LL, Franklin KM, Shahabuddin M, Hellmann GM, Overmeyer JH, Hiremath ST, Siaw MF, Lomonossoff GP, Shaw JG, Rhoads RE: The nucleotide sequence of tobacco vein mottling virus RNA. Nucleic Acids Res. 1986, 14: 5417-5430. 10.1093/nar/14.13.5417.Revers F, Le Gall O, Candresse T, Maule AJ: New advances in understanding the molecular biology of plant/potyvirus interactions. Mol Plant Microbe Interact. 1999, 12: 367-376. 10.1094/MPMI.1999.12.5.367.Urcuqui-Inchima S, Haenni AL, Bernardi F: Potyvirus proteins: a wealth of functions. Virus Res. 2001, 74: 157-175. 10.1016/S0168-1702(01)00220-9.Merits A, Rajamäki M-L, Lindholm P, Runeberg-Roos P, Kekarainen T, Puustinen P, Mäkeläinen K, Valkonen JPT, Saarma M: Proteolytic processing of potyviral proteins and polyprotein processing intermediates in insect and plant cells. J Gen Virol. 2002, 83: 1211-1221.Adams MJ, Antoniw JF, Beaudoin F: Overview and analysis of the polyprotein cleavage sites in the family Potyviridae. Mol Plant Pathol. 2005, 6: 471-487. 10.1111/j.1364-3703.2005.00296.x.Zheng H, Yan F, Lu Y, Sun L, Lin L, Cai L, Hou M, Chen J: Mapping the self-interacting domains of TuMV HC-Pro and the subcellular localization of the protein. Virus Genes. 2011, 42: 110-116. 10.1007/s11262-010-0538-8.Culver JN, Padmanabhan MS: Virus-induced disease: altering host physiology one interaction at a time. Annu Rev Phytopathol. 2007, 45: 221-243. 10.1146/annurev.phyto.45.062806.094422.De Las Rivas J, Fontanillo C: Protein-protein interactions essentials: key concepts to building and analyzing interactome networks. PLoS Comput Biol. 2010, 6: e1000807-10.1371/journal.pcbi.1000807.Bornke F: Protein Interaction Networks. Anal Biol Netw. Edited by: Junker BH, Schreiber F. 2008, John Wiley & Sons, Inc, Hoboken, NJ, USA, 207-232. 10.1002/9780470253489.ch9.Phizicky EM, Fields S: Protein-protein interactions: methods for detection and analysis. Microbiol Rev. 1995, 59: 94-123.Brückner A, Polge C, Lentze N, Auerbach D, Schlattner U: Yeast two-hybrid, a powerful tool for systems biology. Int J Mol Sci. 2009, 10: 2763-2788. 10.3390/ijms10062763.Fields S, Song O: A novel genetic system to detect protein-protein interactions. Nature. 1989, 340: 245-246. 10.1038/340245a0.Ho Y, Gruhler A, Heilbut A, Bader GD, Moore L, Adams S-L, Millar A, Taylor P, Bennett K, Boutilier K, Yang L, Wolting C, Donaldson I, Schandorff S, Shewnarane J, Vo M, Taggart J, Goudreault M, Muskat B, Alfarano C, Dewar D, Lin Z, Michalickova K, Willems AR, Sassi H, Nielsen PA, Rasmussen KJ, Andersen JR, Johansen LE, Hansen LH, et al: Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature. 2002, 415: 180-183. 10.1038/415180a.Hu C-D, Chinenov Y, Kerppola TK: Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell. 2002, 9: 789-798. 10.1016/S1097-2765(02)00496-3.Kodama Y, Hu C-D: An improved bimolecular fluorescence complementation assay with a high signal-to-noise ratio. Biotechniques. 2010, 49: 793-805. 10.2144/000113519.Rual J-F, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, et al: Towards a proteome-scale map of the human protein-protein interaction network. Nature. 2005, 437: 1173-1178. 10.1038/nature04209.Venkatesan K, Rual J-F, Vazquez A, Stelzl U, Lemmens I, Hirozane-Kishikawa T, Hao T, Zenkner M, Xin X, Goh K-I, Yildirim MA, Simonis N, Heinzmann K, Gebreab F, Sahalie JM, Cevik S, Simon C, de Smet A-S, Dann E, Smolyar A, Vinayagam A, Yu H, Szeto D, Borick H, Dricot A, Klitgord N, Murray RR, Lin C, Lalowski M, Timm J, et al: An empirical framework for binary interactome mapping. Nat Methods. 2008, 6: 83-90. 10.1038/nmeth.1280.Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan V, Srinivasan M, Pochart P, Qureshi-Emili A, Li Y, Godwin B, Conover D, Kalbfleisch T, Vijayadamodar G, Yang M, Johnston M, Fields S, Rothberg JM: A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature. 2000, 403: 623-627. 10.1038/35001009.Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y: A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci. 2001, 98: 4569-4574. 10.1073/pnas.061034498.Uetz P, Dong Y-A, Zeretzke C, Atzler C, Baiker A, Berger B, Rajagopala SV, Roupelieva M, Rose D, Fossum E, Haas J: Herpesviral protein networks and their interaction with the human proteome. Science. 2006, 311: 239-242. 10.1126/science.1116804.Fossum E, Friedel CC, Rajagopala SV, Titz B, Baiker A, Schmidt T, Kraus T, Stellberger T, Rutenberg C, Suthram S, Bandyopadhyay S, Rose D, von Brunn A, Uhlmann M, Zeretzke C, Dong Y-A, Boulet H, Koegl M, Bailer SM, Koszinowski U, Ideker T, Uetz P, Zimmer R, Haas J: Evolutionarily conserved herpesviral protein interaction networks. PLoS Pathog. 2009, 5: e1000570-10.1371/journal.ppat.1000570.Rodrigo G, Carrera J, Ruiz-Ferrer V, del Toro FJ, Llave C, Voinnet O, Elena SF: A meta-analysis reveals the commonalities and differences in Arabidopsis thaliana response to different viral pathogens. PLoS One. 2012, 7: e40526-10.1371/journal.pone.0040526.Newman MEJ: The structure and function of complex networks. SIAM Rev. 2003, 45: 167-256. 10.1137/S003614450342480.Watts DJ, Strogatz SH: Collective dynamics of "small-world" networks. Nature. 1998, 393: 440-442. 10.1038/30918.Albert R, Barabási A-L: Statistical mechanics of complex networks. Rev Mod Phys. 2002, 74: 47-97. 10.1103/RevModPhys.74.47.Boccaletti S, Latora V, Moreno Y, Chávez M, Hwang D: Complex networks: structure and dynamics. Phys Rep. 2006, 424: 175-308. 10.1016/j.physrep.2005.10.009.Barabási A-L, Oltvai ZN: Network biology: understanding the cell's functional organization. Nat Rev Genet. 2004, 5: 101-113. 10.1038/nrg1272.Albert R, DasGupta B, Hegde R, Sivanathan GS, Gitter A, Gürsoy G, Paul P, Sontag E: Computationally efficient measure of topological redundancy of biological and social networks. Phys Rev E. 2011, 84: 036117-10.1103/PhysRevE.84.036117.Cho D-Y, Kim Y-A, Przytycka TM: Chapter 5: network biology approach to complex diseases. PLoS Comput Biol. 2012, 8: e1002820-10.1371/journal.pcbi.1002820.Russell RB, Aloy P: Targeting and tinkering with interaction networks. Nat Chem Biol. 2008, 4: 666-673. 10.1038/nchembio.119.Winterbach W, Mieghem PV, Reinders M, Wang H, de Ridder D: Topology of molecular interaction networks. BMC Syst Biol. 2013, 7: 90-10.1186/1752-0509-7-90.Pržulj N: Protein-protein interactions: making sense of networks via graph-theoretic modeling. Bioessays. 2011, 33: 115-123. 10.1002/bies.201000044.Yook S-H, Oltvai ZN, Barabási A-L: Functional and topological characterization of protein interaction networks. Proteomics. 2004, 4: 928-942. 10.1002/pmic.200300636.Pržulj N, Wigle DA, Jurisica I: Functional topology in a network of protein interactions. Bioinformatics. 2004, 20: 340-348. 10.1093/bioinformatics/btg415.Elena SF, Carrera J, Rodrigo G: A systems biology approach to the evolution of plant-virus interactions. Curr Opin Plant Biol. 2011, 14: 372-377. 10.1016/j.pbi.2011.03.013.Zilian E, Maiss E: Detection of plum pox potyviral protein-protein interactions in planta using an optimized mRFP-based bimolecular fluorescence complementation system. J Gen Virol. 2011, 92: 2711-2723. 10.1099/vir.0.033811-0.Lin L, Shi Y, Luo Z, Lu Y, Zheng H, Yan F, Chen J, Chen J, Adams MJ, Wu Y: Protein-protein interactions in two potyviruses using the yeast two-hybrid system. Virus Res. 2009, 142: 36-40. 10.1016/j.virusres.2009.01.006.Guo D, Rajamäki M-L, Saarma M, Valkonen JPT: Towards a protein interaction map of potyviruses: protein interaction matrixes of two potyviruses based on the yeast two-hybrid system. J Gen Virol. 2001, 82: 935-939.Shen WT, Wang MQ, Yan P, Gao L, Zhou P: Protein interaction matrix of papaya ringspot virus type P based on a yeast two-hybrid system. Acta Virol. 2010, 54: 49-54. 10.4149/av_2010_01_49.Kang S, Ws L, Kh K: A protein interaction map of soybean mosaic virus strain G7H based on the yeast two-hybrid system. Mol Cells. 2004, 18: 122-126.Yambao MLM, Masuta C, Nakahara K, Uyeda I: The central and C-terminal domains of VPg of Clover yellow vein virus are important for VPg-HCPro and VPg-VPg interactions. J Gen Virol. 2003, 84: 2861-2869. 10.1099/vir.0.19312-0.Evidence for network evolution in an Arabidopsis interactome map. Science. 2011, 333: 601-607. 10.1126/science.1203877.Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13: 2498-2504. 10.1101/gr.1239303.Fouss F, Francoisse K, Yen L, Pirotte A, Saerens M: An experimental investigation of kernels on graphs for collaborative recommendation and semisupervised classification. Neural Netw Off J Int Neural Netw Soc. 2012, 31: 53-72. 10.1016/j.neunet.2012.03.001.Bass JIF, Diallo A, Nelson J, Soto JM, Myers CL, Walhout AJM: Using networks to measure similarity between genes: association index selection. Nat Methods. 2013, 10: 1169-1176. 10.1038/nmeth.2728.Newman MEJ: Assortative mixing in networks. Phys Rev Lett. 2002, 89: 208701-10.1103/PhysRevLett.89.208701

Detection and Functional Characterization of a 215 Amino Acid N-Terminal Extension in the Xanthomonas Type III Effector XopD

During evolution, pathogens have developed a variety of strategies to suppress plant-triggered immunity and promote successful infection. In Gram-negative phytopathogenic bacteria, the so-called type III protein secretion system works as a molecular syringe to inject type III effectors (T3Es) into plant cells. The XopD T3E from the strain 85-10 of Xanthomonas campestris pathovar vesicatoria (Xcv) delays the onset of symptom development and alters basal defence responses to promote pathogen growth in infected tomato leaves. XopD was previously described as a modular protein that contains (i) an N-terminal DNA-binding domain (DBD), (ii) two tandemly repeated EAR (ERF-associated amphiphillic repression) motifs involved in transcriptional repression, and (iii) a C-terminal cysteine protease domain, involved in release of SUMO (small ubiquitin-like modifier) from SUMO-modified proteins. Here, we show that the XopD protein that is produced and secreted by Xcv presents an additional N-terminal extension of 215 amino acids. Closer analysis of this newly identified N-terminal domain shows a low complexity region rich in lysine, alanine and glutamic acid residues (KAE-rich) with high propensity to form coiled-coil structures that confers to XopD the ability to form dimers when expressed in E. coli. The full length XopD protein identified in this study (XopD1-760) displays stronger repression of the XopD plant target promoter PR1, as compared to the XopD version annotated in the public databases (XopD216-760). Furthermore, the N-terminal extension of XopD, which is absent in XopD216-760, is essential for XopD type III-dependent secretion and, therefore, for complementation of an Xcv mutant strain deleted from XopD in its ability to delay symptom development in tomato susceptible cultivars. The identification of the complete sequence of XopD opens new perspectives for future studies on the XopD protein and its virulence-associated functions in planta

Pooled sequencing of 531 genes in inflammatory bowel disease identifies an associated rare variant in BTNL2 and implicates other immune related genes.

The contribution of rare coding sequence variants to genetic susceptibility in complex disorders is an important but unresolved question. Most studies thus far have investigated a limited number of genes from regions which contain common disease associated variants. Here we investigate this in inflammatory bowel disease by sequencing the exons and proximal promoters of 531 genes selected from both genome-wide association studies and pathway analysis in pooled DNA panels from 474 cases of Crohn's disease and 480 controls. 80 variants with evidence of association in the sequencing experiment or with potential functional significance were selected for follow up genotyping in 6,507 IBD cases and 3,064 population controls. The top 5 disease associated variants were genotyped in an extension panel of 3,662 IBD cases and 3,639 controls, and tested for association in a combined analysis of 10,147 IBD cases and 7,008 controls. A rare coding variant p.G454C in the BTNL2 gene within the major histocompatibility complex was significantly associated with increased risk for IBD (p = 9.65x10-10, OR = 2.3[95% CI = 1.75-3.04]), but was independent of the known common associated CD and UC variants at this locus. Rare (T) or decreased risk (IL12B p.V298F, and NICN p.H191R) of IBD. These results provide additional insights into the involvement of the inhibition of T cell activation in the development of both sub-phenotypes of inflammatory bowel disease. We suggest that although rare coding variants may make a modest overall contribution to complex disease susceptibility, they can inform our understanding of the molecular pathways that contribute to pathogenesis